[go: up one dir, main page]

FR2042375A1 - Anticonvulsive compsn - Google Patents

Anticonvulsive compsn

Info

Publication number
FR2042375A1
FR2042375A1 FR7014997A FR7014997A FR2042375A1 FR 2042375 A1 FR2042375 A1 FR 2042375A1 FR 7014997 A FR7014997 A FR 7014997A FR 7014997 A FR7014997 A FR 7014997A FR 2042375 A1 FR2042375 A1 FR 2042375A1
Authority
FR
France
Prior art keywords
anticonvulsive
compsn
dione
parts
sodium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7014997A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of FR2042375A1 publication Critical patent/FR2042375A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anticonvulsive prepn. consists of 3-allyl-5-isobutyl-2-thiohydantoin; (1 part by wt); 5,5-diphenylimidazolidine-2, 4-dione or its sodium salt, (0.1-10 parts) 5-ethyl-5-phenylbarbituric acid or its sodium salt, (0.01-1 part); and 3,5,5-trimethyloxazolidine-2,4-dione, (1-90 parts).
FR7014997A 1969-04-25 1970-04-24 Anticonvulsive compsn Withdrawn FR2042375A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81944669A 1969-04-25 1969-04-25

Publications (1)

Publication Number Publication Date
FR2042375A1 true FR2042375A1 (en) 1971-02-12

Family

ID=25228189

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7014997A Withdrawn FR2042375A1 (en) 1969-04-25 1970-04-24 Anticonvulsive compsn

Country Status (4)

Country Link
AU (1) AU1427570A (en)
DE (1) DE2018958A1 (en)
FR (1) FR2042375A1 (en)
IL (1) IL34198A0 (en)

Also Published As

Publication number Publication date
AU1427570A (en) 1971-10-28
DE2018958A1 (en) 1970-11-05
IL34198A0 (en) 1970-05-21

Similar Documents

Publication Publication Date Title
CA990871A (en) Treatment of water or aqueous systems
GB1261829A (en) Detergent compositions
CA970908A (en) Stable aqueous dispersions of optical brightening agents
CA931954A (en) Derivatives of 2,4,6-triiodobenzoic acid
CA972745A (en) MANUFACTURE OF .alpha.-6-DEOXYTETRACYCLINES
CA920131A (en) Chlorination of cyanuric acid
FR2042375A1 (en) Anticonvulsive compsn
GB1225019A (en) Sulphonic acid esters
MUROMACHI et al. EFFECT OF IMPURITY ON MACHINABILITY OF BRASS CONTAINING LEAD
CA832907A (en) Stable, highly concentrated solutions of basic dyestuffs
FR3280M (en) 2 ', 3'-di-0-acylated derivatives of 6-aza-uridine.
CA626643A (en) N,n',n''-trisubstituted guanidines
AU1425370A (en) Stabilized solutions of n-halo compound
CA847942A (en) Starch-polyacrylic acid flocculating agent
FR1850M (en) Phenylalanine derivatives.
GB1274142A (en) Benzophenone derivative and conversion to benzodiazepine derivative
CA618693A (en) .alpha.-ACETYLAMINOISOCAPROIC ACID SALTS
CA849992A (en) Organic purification of aqueous solutions of hydrogen peroxide
AU287249B2 (en) Derivatives of 1,3,3-trimethyl-spiro (2'h-1 'benzophyran-2', 2-indoline)
CA941529A (en) Treatment of an aqueous waste stream
CA809691A (en) Stabilization of aqueous formaldehyde solutions
CA637809A (en) Recovery of sodium cyanide from solution
CA698759A (en) PROCESS FOR THE PREPARATION OF 18 .alpha.-GLYCYRRHETINIC ACID
CA795733A (en) Stabilization of aqueous solutions of certain dyes
AU429182B2 (en) Stable, highly concentrated aqueous solutions of basic dyestuffs

Legal Events

Date Code Title Description
ST Notification of lapse